In the pharmaceutical industry, the journey from raw materials to finished medicine is a testament to the power of precise chemical synthesis. At the core of Febuxostat production, a vital medication for gout and hyperuricemia, lies p-Anisaldehyde, also known as 4-Methoxybenzaldehyde (CAS No. 123-11-5). This aromatic aldehyde is more than just a reagent; it's a critical intermediate that forms the chemical foundation for effective gout management.

The role of p-anisaldehyde intermediate for Febuxostat synthesis is multifaceted. Its chemical structure and properties are leveraged in complex reactions to produce Febuxostat, a medication that targets the underlying cause of gout by reducing uric acid levels. The pharmaceutical industry places a premium on the purity of p-Anisaldehyde, typically requiring a minimum of 99.0%, to ensure the integrity and efficacy of the final drug product. This adherence to quality is non-negotiable in producing medicines that impact patient health.

Understanding the 4-Methoxybenzaldehyde CAS 123-11-5 properties is crucial for any entity involved in the Febuxostat supply chain. Its physical characteristics as a colorless to light yellow liquid, coupled with a density of 1.121, a boiling point of 248-249°C, and a flash point of 116°C, dictate its handling, storage, and integration into chemical processes. These parameters are thoroughly documented and adhere to industrial safety and operational standards.

The consistent supply of this febuxostat precursor chemical synthesis is fundamental to meeting the global demand for gout treatment. Pharmaceutical manufacturers rely on dependable suppliers who can deliver p-Anisaldehyde in bulk quantities, often packaged in 200 kg drums. This ensures uninterrupted production and supports the accessibility of Febuxostat to patients worldwide.

The continued study of p-anisaldehyde physical and chemical properties not only supports its current applications but also opens doors for innovation in chemical synthesis. For researchers and manufacturers, a deep understanding of this compound’s behavior and reactivity is essential for process optimization and the development of more efficient synthetic routes. The commitment to high-purity intermediates like p-Anisaldehyde is a critical factor in maintaining the high standards of the pharmaceutical industry.

In summary, p-Anisaldehyde plays a pivotal role in the production of Febuxostat, a key medication in managing gout. Its chemical attributes and reliable supply are indispensable for delivering effective relief to patients, highlighting the critical intersection of chemistry and healthcare.